Target miss using PTV-based IMRT compared to robust optimization via coverage probability concept in prostate cancer

References

• Yu T, Zhang Q, Zheng T, et al. The effectiveness of intensity modulated radiation therapy versus three-dimensional radiation therapy in prostate cancer: a meta-analysis of the literatures. PLoS One. 2016;11(5):e0154499.
   PubMed Web of Science ®Google Scholar
• Bauman G, Rumble RB, Chen J, et al. Intensity-modulated radiotherapy in the treatment of prostate cancer. Clin Oncol. 2012;24(7):461–473.
   Web of Science ®Google Scholar
• NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Prostate Cancer Version 1.2020. Plymouth Meeting, PA: National Comprehensive Cancer Network; 2020. Available from: www.nccn.org
   Google Scholar
• Leitlinienprogramm Onkologie der AWMW DKeVu, e.V DK. Interdisziplinäre leitlinie der qualität s3 zur früherkennung, diagnose und therapie der verschiedenen stadien des prostatakarzinoms. German S3-Guideline. Langversion 5.0. 2018;1–394. Available from: https://www.leitlinienprogramm-onkologie.de/fileadmin/user_upload/Downloads/Leitlinien/Prostata_5_0/LL_Prostata_Langversion_5.0.pdf
   Google Scholar
• Thorwarth D, Notohamiprodjo M, Zips D, et al. Personalized precision radiotherapy by integration of multi-parametric functional and biological imaging in prostate cancer: a feasibility study. Z Med Phys. 2017;27(1):21–30.
   PubMed Web of Science ®Google Scholar
• Engels B, Soete G, Gevaert T, et al. Impact of planning target volume margins and rectal distention on biochemical failure in image-guided radiotherapy of prostate cancer. Radiother Oncol. 2014;111(1):106–109.
   PubMed Web of Science ®Google Scholar
• Storey MR, Pollack A, Zagars G, et al. Complications from radiotherapy dose escalation in prostate cancer: preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys. 2000;48(3):635–642.
   PubMed Web of Science ®Google Scholar
• Michalski JM, Bae K, Roach M, et al. Long-term toxicity following 3d conformal radiation therapy for prostate cancer from the rtog 9406 phase i/ii dose escalation study. Int J Radiat Oncol Biol Phys. 2010;76(1):14–22.
   PubMed Web of Science ®Google Scholar
• Eckert F, Alloussi S, Paulsen F, et al. Prospective evaluation of a hydrogel spacer for rectal separation in dose-escalated intensity-modulated radiotherapy for clinically localized prostate cancer. BMC Cancer. 2013;13(1):27.
   PubMed Web of Science ®Google Scholar
• Dearnaley D, Syndikus I, Mossop H, et al. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 chhip trial. Lancet Oncol. 2016;17(8):1047–1060.
   PubMed Web of Science ®Google Scholar
• Baum C, Alber M, Birkner M, et al. Robust treatment planning for intensity modulated radiotherapy of prostate cancer based on coverage probabilities. Radiother Oncol. 2006;78(1):27–35.
   PubMed Web of Science ®Google Scholar
• Baum C, Birkner M, Alber M, et al. Dosimetric consequences of the application of off-line setup error correction protocols and a hull-volume definition strategy for intensity modulated radiotherapy of prostate cancer. Radiother Oncol. 2005;76:35–42.
   PubMed Web of Science ®Google Scholar
• Wegener D, Berger B, Outaggarts Z, et al. Probabilistic planning concept instead of target volume margins - prospective evaluation. Radiother Oncol. 2018;127:S864–S865.
   Web of Science ®Google Scholar
• Unkelbach J, Alber M, Bangert M, et al. Robust radiotherapy planning. Phys Med Biol. 2018;63(22):22TR02–22TR02.
   PubMed Web of Science ®Google Scholar
• Viani GA, Stefano EJ, Afonso SL. Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials. Int J Radiat Oncol Biol Phys. 2009;74(5):1405–1418.
   PubMed Web of Science ®Google Scholar
• Marks LB, Yorke ED, Jackson A, et al. Use of normal tissue complication probability models in the clinic. *International Journal of Radiation Oncology*Biology*Physics. 2010;76(3):S10–S19.
   Web of Science ®Google Scholar
• Tøndel H, Lund J-Å, Lydersen S, et al. Radiotherapy for prostate cancer – does daily image guidance with tighter margins improve patient reported outcomes compared to weekly orthogonal verified irradiation? Results from a randomized controlled trial. Radiother Oncol. 2018;126(2):229–235.
   PubMed Web of Science ®Google Scholar
• Ballhausen H, Li M, Hegemann NS, et al. Intra-fraction motion of the prostate is a random walk. Phys Med Biol. 2015;60(2):549–563.
   PubMed Web of Science ®Google Scholar
• Ramlov A, Assenholt MS, Jensen MF, et al. Clinical implementation of coverage probability planning for nodal boosting in locally advanced cervical cancer. Radiother Oncol. 2017;123(1):158–163.
   PubMed Web of Science ®Google Scholar
• Yan D, Lockman D, Brabbins D, et al. An off-line strategy for constructing a patient-specific planning target volume in adaptive treatment process for prostate cancer. Int J Radiat Oncol Biol Phys. 2000;48(1):289–302.
   PubMed Web of Science ®Google Scholar
• Wegener D, Zips D, Thorwarth D, et al. Precision of t2 tse mri-ct-image fusions based on gold fiducials and repetitive t2 tse mri-mri-fusions for adaptive igrt of prostate cancer by using phantom and patient data. Acta Oncol. 2019;58(1):88–94.
   PubMed Web of Science ®Google Scholar
• McPartlin AJ, Li XA, Kershaw LE, et al. Mri-guided prostate adaptive radiotherapy – a systematic review. Radiother Oncol. 2016;119(3):371–380.
   PubMed Web of Science ®Google Scholar
• Burridge N, Amer A, Marchant T, et al. Online adaptive radiotherapy of the bladder: small bowel irradiated-volume reduction. Inter J Radiation Oncol Biol Phys. 2006;66(3):892–897.
   PubMed Web of Science ®Google Scholar